![]() |
市場調查報告書
商品編碼
1383307
到 2030 年的全球二氧化碳圖設備市場預測:按產品、技術、應用、最終用戶和地區進行分析Capnography Equipment Market Forecasts to 2030 - Global Analysis By Product, By Technology, By Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球二氧化碳監測設備市場規模為 3.781 億美元,預計在預測期內年複合成長率為 6.4%,到 2030 年達到 5.837 億美元。
二氧化碳圖設備市場包括用於監測和檢測患者呼出氣中二氧化碳 (CO2) 濃度的設備,通常在醫療手術和呼吸監測期間使用。二氧化碳圖設備在各種臨床環境中至關重要,透過提供患者呼吸狀態的即時回饋來確保患者安全。其好處包括及早發現通氣不足、氣道阻塞和其他呼吸系統問題。
據疾病預防和健康促進辦公室稱,美國有超過 2500 萬人患有氣喘。
隨著外科手術變得越來越普遍和複雜,在給藥期間準確、即時監測患者呼吸狀態的需求變得至關重要。二氧化碳圖設備提供口腔二氧化碳水平的連續資料,使醫療專業人員能夠快速檢測和解決潛在的呼吸系統問題,包括通氣不足和氣道問題。我會做到的。隨著一般外科、整形外科、腹腔鏡手術等各專科手術需求的不斷增加,二氧化碳圖設備的需求量激增,以確保手術過程中病患的安全和最佳效果,它已成為不可或缺的工具。
二氧化碳圖設備需要正確的設定、校準和維護,以提供準確可靠的呼吸監測。缺乏合格的人員來操作和維護這些設備可能會導致使用效果不佳、資料誤解並降低患者安全。醫療設備很複雜,需要專門的培訓,這帶來了挑戰,特別是在面臨人員短缺的醫療機構中。為了解決這一限制,投資於培訓計劃、使用者友好介面和遠端支援服務將提高醫療保健專業人員的能力,增強二氧化碳圖設備的有效使用,並最終患者照護。
隨著醫學界不斷認知到二氧化碳圖在患者照護中的價值,越來越多的研究和臨床研究正在進行中,為其有效性提供了堅實的證據。這些證據的累積支持二氧化碳圖在各種醫療環境中的使用,包括手術、急診醫學和重症醫學。醫療保健提供者和機構可以利用這項研究就將二氧化碳圖設備涵蓋其實踐做出更資訊的決策。宣傳二氧化碳圖的好處,提高普及,並確保改善患者的治療效果,同時增加市場成長機會。
由於政府法規和核准流程因地區而異,製造商面臨著應對複雜環境的挑戰。嚴格的要求和不明確的法規指南導致產品開發和市場進入的延遲,增加了合規成本和上市時間。法規模糊也可能導致產品核可的誤解和不一致,從而阻礙市場成長和創新。這種威脅導致人們關注法規合規性和透明度,以及行業協作,以簡化和標準化核准流程,確保及時有效地引入二氧化碳圖設備,同時保持高安全標準。
COVID-19 大流行對二氧化碳圖設備市場產生了重大影響。這種病毒對呼吸系統的影響導致對二氧化碳圖設備的需求激增,特別是在重症監護和緊急情況下。二氧化碳圖在監測 COVID-19 患者的呼吸狀態方面發揮了重要作用,尤其是那些使用人工呼吸器的患者。這次疫情凸顯了早期發現呼吸窘迫的重要性,並加速了二氧化碳圖設備的採用。然而,供應鏈中斷和醫療資源緊張也是問題。雖然市場需求增加,但由於醫療機構優先考慮呼吸監測,製造和分銷面臨障礙。這場大流行再形成了二氧化碳圖設備的格局,並凸顯了其在現代醫學中的作用。
獨立設備預計將佔據二氧化碳圖設備市場的很大佔有率。這些設備被設計為專用的獨立裝置,用於即時監測患者的吐氣末二氧化碳水平。它自主運行,使其具有高度通用性,適用於各種臨床環境。獨立二氧化碳圖設備廣泛用於急診室、加護病房、手術室和病人轉運過程。其攜帶性和易用性使其成為持續呼吸監測的寶貴工具。用於監測和改善呼吸功能的最新醫療設備在檢測通氣不足和插管問題等呼吸問題以及確保患者安全和最佳護理方面發揮著至關重要的作用,已成為不可或缺的一部分。
預計醫院部門在預測期內將以最有效的速度成長。這些醫療機構廣泛使用二氧化碳圖設備來持續監測患者的吐氣末二氧化碳濃度。在醫院,二氧化碳圖被整合到急診室、手術室、加護病房和普通病房等各個部門。該設備有助於早期發現呼吸系統併發症,確保及時介入並提高患者安全。它在麻醉管理、機械通氣和重症監護情況下非常有效。醫院依靠二氧化碳圖設備來加強呼吸評估、監測鎮靜患者並確保最佳呼吸功能,使其成為現代醫學的重要工具。
在預測期內,由於其成熟的醫療部門、對病人安全的重視和先進的醫療技術,北美二氧化碳監測設備市場預計將佔據大部分市場佔有率。該地區的醫療機構,包括醫院和門診手術中心,正在優先考慮二氧化碳監測儀,因為它在早期發現呼吸系統併發症方面發揮著重要作用。隨著呼吸系統疾病盛行率的不斷增加,人們對二氧化碳圖重要性的認知不斷提高,推動了北美對二氧化碳圖設備的需求,並對全球市場做出了重大貢獻。
由於人們越來越認知到二氧化碳圖監測在醫療保健中的重要性,預計亞太地區在預測期內將出現最高的年複合成長率。該地區對先進醫療技術和改善患者照護的需求不斷成長。二氧化碳圖是監測吐氣末二氧化碳水平和呼吸功能的重要工具,廣泛應用於重症監護、麻醉和急診醫學。隨著醫療保健基礎設施的改善,二氧化碳圖設備的採用越來越多,以確保病人安全和早期發現呼吸系統問題。此外,亞太地區高齡化和呼吸系統疾病的流行進一步促進了亞太地區二氧化碳監測設備市場的擴張。
According to Stratistics MRC, the Global Capnography Equipment Market is accounted for $378.1 million in 2023 and is expected to reach $583.7 million by 2030 growing at a CAGR of 6.4% during the forecast period. The Capnography Equipment Market encompasses devices used to monitor and measure the concentration of carbon dioxide (CO2) in a patient's exhaled breath, typically during medical procedures or respiratory monitoring. Capnography equipment is essential in various clinical settings, ensuring patient safety by providing real-time feedback on their respiratory status. Its advantages include early detection of hypoventilation, airway obstructions, or other respiratory issues.
According to the office of disease prevention and health promotion, more than 25 million people in the USA are suffering from Asthma.
As surgical procedures become more common and complex, the need for accurate and real-time monitoring of patients' respiratory status during anesthesia administration is paramount. Capnography equipment provides continuous data on end-tidal carbon dioxide levels, enabling healthcare professionals to swiftly detect and address potential respiratory issues, including hypoventilation and airway problems. With the rising demand for surgical interventions across various medical specialties, such as general surgery, orthopedics, and laparoscopy, the demand for capnography equipment has surged, making it an indispensable tool to ensure patient safety and optimal outcomes during surgery.
Capnography devices require proper setup, calibration, and maintenance to ensure accurate and reliable respiratory monitoring. A lack of qualified personnel to operate and maintain these instruments can result in suboptimal usage, misinterpretation of data, and decreased patient safety. The complexity of medical equipment and the need for specialized training can create challenges, particularly in healthcare settings facing staff shortages. To address this restraint, investment in training programs, user-friendly interfaces, and remote support services can empower healthcare professionals and enhance the effective use of capnography equipment, ultimately improving patient care.
As the medical community continues to recognize the value of capnography in patient care, more research and clinical studies are conducted, providing robust evidence of its efficacy. This growing body of evidence strengthens the case for capnography's use in various medical settings, including surgery, emergency care, and critical care. Healthcare providers and institutions can leverage this research to make more informed decisions about integrating capnography equipment into their practices. The opportunity lies in promoting the benefits of capnography, driving greater adoption, and ensuring improved patient outcomes while enhancing the market's growth prospects.
Government regulations and approval procedures vary across regions, making it challenging for manufacturers to navigate the complex landscape. Stringent requirements and unclear regulatory guidelines can lead to delays in product development and market entry, increasing compliance costs and time-to-market. Ambiguities in regulations may also result in misinterpretations and inconsistencies in product approvals, hindering market growth and innovation. This threat necessitates a strong focus on regulatory compliance and transparency, as well as industry collaboration to streamline and standardize approval processes, ensuring the timely and efficient introduction of capnography equipment while maintaining high safety standards.
The COVID-19 pandemic had a significant impact on the Capnography Equipment Market. With the virus's respiratory implications, the demand for capnography equipment surged, particularly in the critical care and emergency settings. Capnography played a crucial role in monitoring the respiratory status of COVID-19 patients, especially those on ventilators. The pandemic underscored the importance of early detection of respiratory distress, driving the adoption of capnography devices. However, supply chain disruptions and the strain on healthcare resources also presented challenges. As healthcare facilities prioritized respiratory monitoring, the market experienced increased demand, but manufacturing and distribution faced obstacles. The pandemic reshaped the landscape of capnography equipment, emphasizing its role in modern healthcare.
Stand-alone in the Capnography Equipment Market is expected to hold a significant share. These devices are designed as dedicated, independent units that provide real-time monitoring of end-tidal carbon dioxide levels in patients. They operate autonomously, making them versatile and applicable in various clinical settings. Stand-alone capnography equipment is widely used in emergency rooms, intensive care units, operating rooms, and during patient transport. Their portability and ease of use make them valuable tools for continuous respiratory monitoring. They play a critical role in detecting respiratory issues, such as hypoventilation and intubation problems, ensuring patient safety and optimal care, and are an integral part of modern healthcare equipment for monitoring and improving respiratory function.
During the anticipated period, the hospitals segment is expected to increase at the most effective rate. These medical facilities extensively utilize capnography equipment for continuous monitoring of patients' end-tidal carbon dioxide levels. In hospitals, capnography is integrated into various departments, including emergency rooms, operating rooms, intensive care units, and general wards. The equipment aids in the early detection of respiratory complications, ensuring timely intervention and improving patient safety. It is instrumental during anesthesia administration, mechanical ventilation, and critical care scenarios. Hospitals rely on capnography equipment to enhance respiratory assessment, monitor sedated patients, and ensure optimal respiratory function, making it an indispensable tool for modern healthcare.
During the forecast period, it is expected that the North American Capnography Equipment market will hold a majority of the market share driven by its well-established healthcare sector and a strong emphasis on patient safety and advanced medical technologies. The region's healthcare facilities, including hospitals and ambulatory surgery centers, prioritize Capnography for its role in early detection of respiratory complications. The growing awareness of the importance of Capnography, along with the increasing prevalence of respiratory conditions, propels the demand for Capnography equipment in North America, making it a significant contributor to the global market.
Asia Pacific is projected to have the highest CAGR over the forecast period driven by increasing awareness of the significance of capnography monitoring in healthcare. The region experiences a growing demand for advanced medical technologies and improved patient care. Capnography, a vital tool for monitoring end-tidal carbon dioxide levels and respiratory function, is extensively used in critical care, anaesthesia, and emergency medicine. As healthcare infrastructure improves, the adoption of Capnography equipment for patient safety and early detection of respiratory issues is on the rise. Additionally, the region's aging population and the prevalence of respiratory conditions further contribute to the expansion of the Capnography Equipment Market in Asia Pacific.
Some of the key players in Capnography Equipment market include: Diamedica Ltd., Dragerwerk AG & Co. KGaA, Koninklijke Philips N.V., Bionics, BPL Medical Technologies, Burtons Medical Equipment Ltd., Criticare Technologies Inc., Masimo, Edan Instruments, Inc., GE Healthcare, Hamilton Medical, Nihon Kohden Corp., Medtronic, Mindray Medical, ZOLL Medical, Nonin Medical, Inc., Smiths Medical and Welch Allyn (Hill-Rom Holdings, Inc.).
In November 2022, Masimo received U.S.FDA approval for NOMOLINE capnography sampling lines having more than 40 configurations of airway adapter sets and cannulas which can be used for both intubated and non- intubated patients and various other medical scenarios.
In October 2022, Masimo and Royal Philips, both global pioneers in patient monitoring, announced that they have strengthened their cooperation, with Philips integrating additional Masimo measurement technologies into certain IntelliVue MX-series multiparameter monitors to assist clinicians in assessing cerebral oximetry and ventilation status.
In June 2022, Nonin launched its next-generation LIFESENSE II and RESPONSE II Stand-Alone Capnometers, with high accuracy, ease of use, cost-effectiveness and having a wide range of applications.